ATE322891T1 - Arzneistoffabgabesystem für wasser schwerlösliche arzneimittel - Google Patents

Arzneistoffabgabesystem für wasser schwerlösliche arzneimittel

Info

Publication number
ATE322891T1
ATE322891T1 AT01951278T AT01951278T ATE322891T1 AT E322891 T1 ATE322891 T1 AT E322891T1 AT 01951278 T AT01951278 T AT 01951278T AT 01951278 T AT01951278 T AT 01951278T AT E322891 T1 ATE322891 T1 AT E322891T1
Authority
AT
Austria
Prior art keywords
water
soluble drugs
delivery system
drug delivery
hydrogels
Prior art date
Application number
AT01951278T
Other languages
English (en)
Inventor
Esteban Chornet
Claudia Ishizawa
Severian Dumitriu
Original Assignee
Kemestrie Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kemestrie Inc filed Critical Kemestrie Inc
Application granted granted Critical
Publication of ATE322891T1 publication Critical patent/ATE322891T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Colloid Chemistry (AREA)
AT01951278T 2000-07-07 2001-07-06 Arzneistoffabgabesystem für wasser schwerlösliche arzneimittel ATE322891T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21662700P 2000-07-07 2000-07-07
US25238900P 2000-11-21 2000-11-21

Publications (1)

Publication Number Publication Date
ATE322891T1 true ATE322891T1 (de) 2006-04-15

Family

ID=26911183

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01951278T ATE322891T1 (de) 2000-07-07 2001-07-06 Arzneistoffabgabesystem für wasser schwerlösliche arzneimittel

Country Status (12)

Country Link
US (1) US20030157171A1 (de)
EP (1) EP1299089B1 (de)
JP (1) JP2004502722A (de)
AT (1) ATE322891T1 (de)
AU (1) AU2001272262A1 (de)
BR (1) BR0112258A (de)
CA (1) CA2415081A1 (de)
DE (1) DE60118742D1 (de)
IL (1) IL153814A0 (de)
NO (1) NO20030073L (de)
NZ (1) NZ523418A (de)
WO (1) WO2002003962A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003290345A1 (en) * 2003-12-24 2005-07-14 Astrazeneca Ab Pharmaceutical dissolution testing using a non-ionic surfactant
IL160095A0 (en) * 2004-01-28 2004-06-20 Yissum Res Dev Co Formulations for poorly soluble drugs
CN101217944A (zh) * 2005-04-08 2008-07-09 艾博特公司 包含非诺贝酸和/或其盐的口服药物制剂
RU2008116721A (ru) * 2005-09-28 2009-11-10 ДиЭнПи КЭНАДА ИНК. (CA) Комбинация полихитозамина и фибрата для предотвращения и лечения гиперлипидемии
CN101299993A (zh) * 2005-11-04 2008-11-05 伊士曼化工公司 用于给药难溶的药学活性剂的羧烷基纤维素酯
ES2539761T3 (es) 2006-04-05 2015-07-03 Woodland Biofuels Inc. Sistema y método para convertir biomasa en etanol a través del gas de síntesis
CA2682291C (en) * 2007-04-19 2013-08-13 Medovent Gmbh Device made at least partially of n-acetylchitosan with controlled biodissolution
CA2810842C (en) 2010-09-09 2018-06-26 Micell Technologies, Inc. Macrolide dosage forms
EP2739269A2 (de) 2011-08-01 2014-06-11 Ranbaxy Laboratories Limited Wirkstoffreisetzungssystem mit kontrollierter freisetzung und verbesserter auflösung für arzneimittel mit schlechter löslichkeit in wasser
CN103315960A (zh) * 2012-03-19 2013-09-25 胡容峰 基于球晶技术固体自微乳及其制备方法
WO2019064231A1 (en) * 2017-09-27 2019-04-04 Association For The Advancement Of Tissue Engineering And Cell Based Technologies & Therapies (A4Tec) - Associação HIGH MOLECULAR WEIGHT CHITOSAN, METHOD FOR PRODUCING THE SAME AND USES THEREOF
KR102407470B1 (ko) * 2021-08-09 2022-06-10 인제대학교 산학협력단 하이드로겔에 담지된 약물의 방출량 검출 방법
CN114515268B (zh) * 2022-02-21 2024-06-21 上海宣泰医药科技股份有限公司 熊去氧胆酸药物组合物及其制备方法和药物制剂

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5620706A (en) * 1995-04-10 1997-04-15 Universite De Sherbrooke Polyionic insoluble hydrogels comprising xanthan and chitosan
CA2243619A1 (fr) * 1998-07-17 2000-01-17 Universite De Sherbrooke Hydrogels polyioniques a base de xanthane et chitosane pour stabilisation et relargage controle des vitamines

Also Published As

Publication number Publication date
WO2002003962A3 (en) 2002-06-13
NO20030073L (no) 2003-03-06
NO20030073D0 (no) 2003-01-07
EP1299089B1 (de) 2006-04-12
AU2001272262A1 (en) 2002-01-21
IL153814A0 (en) 2003-07-31
WO2002003962A2 (en) 2002-01-17
BR0112258A (pt) 2003-06-24
NZ523418A (en) 2004-09-24
CA2415081A1 (en) 2002-01-17
US20030157171A1 (en) 2003-08-21
EP1299089A2 (de) 2003-04-09
JP2004502722A (ja) 2004-01-29
DE60118742D1 (de) 2006-05-24

Similar Documents

Publication Publication Date Title
ATE322891T1 (de) Arzneistoffabgabesystem für wasser schwerlösliche arzneimittel
MXPA02009275A (es) Metodo para preparar dispersiones de alta presion/alto esfuerzo cortante que contienen ingredientes fisiologicamente activos.
TWI256891B (en) 17alpha-alkyl-17beta-oxy-estratrienes and intermediate products for their production, use of the 17alpha-alkyl-17beta-oxy-estratrienes for the production of pharmaceutical agents as well as pharmaceutical preparations
CY1110878T1 (el) Διαδικασιες για την μετρηση της ισχυος του glatiramer acetate
FR16C0030I1 (fr) Glycoproteine d'hyaluronidase soluble (shasegp), son procede de preparation, utilisations et compositions pharmaceutiques le comportant
HK1046527A1 (zh) 金剛烷衍生物
MY125978A (en) Admantane derivatives
ATE389385T1 (de) Ophthalmische depot-formulierungen zur periokkularen oder subkonjunktivalen verabreichung
WO2001026693A3 (en) Manufacture of polyglutamate-therapeutic agent conjugates
PL364598A1 (en) Stable polymorph of flibanserin, technical process for its preparation and the use thereof for preparing medicaments
DE69924004D1 (de) Verabreichungssystem für wasserunlösliche arzneistoffe
PL1643833T3 (pl) Formulacje agrochemiczne
WO2004050057A3 (en) An exopolysaccharides delivery system for active molecules
EA200400455A1 (ru) Способ приготовления быстрорастворимой дозировочной формы
FI980862A0 (fi) Kiraalisia metyylifenyylioksatsolidinoneja
HUP0401811A2 (hu) Javított vízoldékonyságú gyógyszerkészítmény és eljárás az előállítására
NO20014101L (no) Stabilisert oral farmasöytisk blanding inneholdende iodid og iodat og fremgangsmåte
IL150528A0 (en) Ibuprofen containing active agent preparation
CA2407795A1 (en) Fluorescein isothiocyanate (fitc) sinistrin, its production and use
DE60209359D1 (de) Lösungsmittelverklebungsverfahren
MXPA05008902A (es) Soluciones de drogas en mentol.
CY1111960T1 (el) Νεα φαρμακευτικα παρασκευασματα καθως επισης μεθοδος για την παρασκευη αυτων
AU7599900A (en) Formulations of paclitaxel entrapped into nanoparticles of polymeric micelles
EP1283042A4 (de) Wässrige flüssige preparation
AU2001284189A1 (en) Modified release formulation

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties